Patent · US Active

Compositions to regulate renalase in the treatment of diseases and disorders

US10273311B2 · kind B2 · utility

1Cited by

1References

8Claims

0Family size

Assignee

Yale University · US

Inventors

Gary Desir · Woodbridge, US
Abigail Hunt · Alameda, US
Jessica O-Rear · Redwood City, US
Peter Flynn · San Diego, US

Key dates

Filing date	Jun 26, 2015
Grant date	Apr 30, 2019
Priority date	—
Expiry date	Sep 11, 2035

Classification

Technology area (CPC G)Physics
CPC primaryG01N2333/90209
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention provides compositions and methods for binding and inhibiting renalase. In one embodiment, the renalase binding molecule inhibits renalase activity. Thus, in diseases and conditions where a reduction of renalase activity is beneficial, such inhibitory renalase binding molecules act as therapeutics.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.